![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » PFIZER ACQUIRES GLOBAL RIGHTS OF SCHWARZ PHARMA'S NEW DRUG
PFIZER ACQUIRES GLOBAL RIGHTS OF SCHWARZ PHARMA'S NEW DRUG
June 13, 2006
Pharmaceutical giant Pfizer Inc (PFE.NYS) Tuesday announced that it had completed the acquisition of the worldwide rights of Schwarz Pharma AG's (SRZ) new drug candidate, fesoterodine, for the treatment of an overactive bladder.
Newratings (http://www.newratings.com/analyst_news/article_1296059.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct